E. Liow

发表

Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Recent Advances and Ongoing Challenges.

H. Prenen, E. Segelov, A. Body, 2021, Clinical colorectal cancer.

Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study.

T. Powles, G. De Velasco, A. Hansen, 2021, Clinical Genitourinary Cancer.

89Zirconium-labelled girentuximab (89Zr-TLX250) PET in Urothelial Cancer Patients (ZiPUP): protocol for a phase I trial of a novel staging modality for urothelial carcinoma

A. Redfern, N. Lenzo, P. Viswambaram, 2022, BMJ Open.

High‐dose chemotherapy for relapsed germ cell tumours: outcomes in low‐volume specialized centres

G. Heller, J. Lewin, B. Tran, 2022, BJU international.

A phase I open label dose‐escalation study to evaluate the tolerability, safety and immunological efficacy of sub‐urothelial durvalumab injection in adults with muscle‐invasive or high‐risk non‐muscle‐invasive bladder cancer (SUBDUE‐1, SUB‐urothelial DUrvalumab injection‐1 study): clinical trial pro

I. Davis, A. Redfern, Dickon Hayne, 2021, BJU international.

Role for a Web-Based Intervention to Alleviate Distress in People With Newly Diagnosed Testicular Cancer: Mixed Methods Study

P. Gibbs, N. Lawrentschuk, N. Corcoran, 2022, JMIR cancer.

Role for a Web-Based Intervention to Alleviate Distress in People With Newly Diagnosed Testicular Cancer: Mixed Methods Study

P. Gibbs, N. Lawrentschuk, N. Corcoran, 2022, JMIR cancer.

An update on the use of immunotherapy in patients with colorectal cancer

H. Prenen, E. Segelov, M. Nguyen, 2020, Expert review of gastroenterology & hepatology.

Phase 2 Study of Neoadjuvant FGFR Inhibition and Androgen Deprivation Therapy Prior to Prostatectomy.

A. Costello, N. Corcoran, C. Hovens, 2022, Clinical genitourinary cancer.

First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium.

C. Porta, T. Choueiri, G. De Velasco, 2019, European urology.

Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial.

B. Tran, S. Siva, Jianjun Yu, 2021, European urology.

Sub-urothelial durvalumab injection-1 (SUBDUE-1): A novel approach to immunotherapy for bladder cancer.

I. Davis, A. Redfern, P. Viswambaram, 2021 .

Precision oncology in urothelial cancer

B. Tran, E. Liow, 2020, ESMO Open.

Treatment de-escalation for stage II seminoma

J. Shamash, B. Tran, P. Rajan, 2023, Nature Reviews Urology.

Adding mitomycin to Bacillus Calmette-Guérin as adjuvant intravesical therapy for high-risk, nonmuscle-invasive urothelial bladder cancer (BCGMM; ANZUP 1301).

M. Stockler, M. Frydenberg, I. Davis, 2020 .

Pembrolizumab with chemoradiotherapy as treatment for muscle invasive bladder cancer: A planned interim analysis of safety and efficacy of the PCR-MIB phase II clinical trial (ANZUP 1502).

N. Lawrentschuk, I. Davis, P. Grimison, 2020 .

Application of IMDC criteria across first-line (1L) and second-line (2L) therapies in metastatic renal-cell carcinoma (mRCC): New and updated benchmarks of clinical outcomes.

T. Powles, T. Choueiri, N. Agarwal, 2020 .

Alcohol misuse is rare among Hong Kong medical students.

T. Rainer, C. Graham, G. Cattermole, 2011, Drug and alcohol review.

THERM: the Resuscitation Management score. A prognostic tool to identify critically ill patients in the emergency department

T. Rainer, C. Graham, G. Cattermole, 2013, Emergency Medicine Journal.

Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort.

F. Parnis, A. Weickhardt, J. Torres, 2023, Journal of geriatric oncology.

SUB-urothelial durvalumab injection: 1 (SUBDUE-1)—Results from the first nine urothelial cancer patients using a dose-escalation schedule.

I. Davis, A. Redfern, C. Hawks, 2022, Journal of Clinical Oncology.